E22.2

Clinical Causes: Certain types of cancers, especially small cell lung cancer Pulmonary diseases like pneumonia or tuberculosis Central nervous system disorders such as head injuries, brain tumors, or infections Medications that stimulate ADH release or increase its effect, including antidepressants, antipsychotics, and certain anticonvulsants Surgical procedures involving the brain or neck Genetic predispositions in some rare cases

Key Symptoms: Nausea and vomiting Headache or feeling of confusion Muscle weakness or cramps Disorientation or difficulty concentrating Seizures in severe cases Decreased urine output with increased water retention Swelling or edema in some cases

Diagnosis Path: Diagnosis of SIADH typically involves a combination of laboratory tests and clinical assessment. Key diagnostic steps include and are not limited to: - Blood tests showing low serum sodium levels (hyponatremia) - Low serum osmolality, indicating diluted blood - Elevated urine osmolality and sodium levels, despite low serum sodium - Evaluation to rule out other causes of hyponatremia Additionally, medical history and physical examination help identify underlying causes or related conditions.

Treatment Protocols: Managing SIADH involves addressing both the symptoms and the underlying cause. Typical approaches include: - Fluid restriction to prevent further dilution of blood sodium - Careful correction of sodium levels, sometimes using saline solutions under medical supervision - Medications like vasopressin receptor antagonists (vaptans) to block the effect of ADH - Treating or removing the underlying cause, such as stopping offending medications or treating infections In cases of severe hyponatremia, hospitalization and close monitoring are essential to prevent complications like brain swelling or seizures.